Importantly, cholesin-GPR146 axis holds promise as a therapeutic target for hyperlipidemia and atherosclerosis [2, 3], and the team already hinted at possible synergism with statin treatment [1]. The gene discussed is GPR146; the disease is atherosclerosis.